David Preiss

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Low Density Lipoprotein

Community Dwelling

Top Venues

BMJ quality & safety

Journal of the American Society of Nephrology : JASN

Clinical journal of the American Society of Nephrology : CJASN

This page only lists publications with an associated author ORCID identifier.

Publications

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, Parminder K Judge, Doreen Zhu, Emily Sammons, David Zi Cherney, Alfred K Cheung, Aldo Pietro Maggioni, Masaomi Nangaku, Xavier Rossello, Katherine R Tuttle, Katsuhito Ihara, Tomoko Iwata, Christoph Wanner, Jonathan R Emberson, David Preiss, Martin J Landray, Colin Baigent FMedSci, Richard Haynes, William G Herrington, null null
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial. Clinical journal of the American Society of Nephrology : CJASN (2024)
Kaitlin J Mayne, Natalie Staplin, David F Keane, Christoph Wanner, Susanne Brenner, Vladimir Cejka, Johannes Stegbauer, Parminder K Judge, David Preiss, Jonathan R Emberson, Daniele Trinca, Rejive Dayanandan, Ryonfa Lee, John Nolan, Akiko Omata, Jennifer B Green, David Zi Cherney, Lai-Seong Hooi, Roberto Pontremoli, Katherine R Tuttle, Jennifer Susan Lees, Patrick B Mark, Simon J Davies, Sibylle J Hauske, Dominik Steubl, Martina Brueckmann, Martin J Landray, Colin Baigent FMedSci, Richard Haynes, William G Herrington, null null
Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease. Journal of the American Society of Nephrology : JASN (2023)
Inna Thalmann, David Preiss, Iryna Schlackow, Alastair M Gray, Borislava Mihaylova
Quality of care for secondary cardiovascular disease prevention in 2009-2017: population-wide cohort study of antiplatelet therapy use in Scotland. BMJ quality & safety (2023)
Ciaran N Kohli-Lynch, James Lewsey, Kathleen Anne Boyd, Dustin D French, Neil Jordan, Andrew E Moran, Naveed Sattar, David Preiss, Andrew H Briggs
Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. Circulation 145 (17) (2022)
Inna Thalmann, David Preiss, Iryna Schlackow, Alastair M Gray, Borislava Mihaylova
Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017. Heart (British Cardiac Society) (2022)
David Preiss, Enti Spata, Rury R Holman, Ruth L Coleman, Laura Lovato, Henry N Ginsberg, Jane Armitage
Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials. Diabetes care (2021)